Amgen (AMGN)

I think this stock is at a very solid price and recommend it based on valuation alone. It's P/E ratio is ridiculously low right now, and compared to it's main competitor DNA, it is about half of it's PE ratio.

If I had more money, I would double up on the 100 shares that I already own since it took a hit these last few days too.